Related Experiment Video

Updated: Jul 4, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials

A Schrauder1, A von Stackelberg, M Schrappe

  • 1Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Bone Marrow Transplantation
|July 24, 2008
PubMed

Insights

Allogeneic stem cell transplantation (SCT) offers hope for children with high-risk acute lymphoblastic leukemia (ALL). Standardized international trials aim to improve outcomes for these young patients undergoing SCT.

Area of Science:

  • Pediatric Hematology Oncology
  • Hematopoietic Stem Cell Transplantation
  • Leukemia Research

Background:

  • Defining indications for allogeneic stem cell transplantation (SCT) in pediatric high-risk (HR) acute lymphoblastic leukemia (ALL) is complex, influenced by disease biology and treatment response.
  • Improving outcomes in frontline and relapse protocols necessitate standardized prospective SCT trials to address heterogeneity in post-transplant results.

Purpose of the Study:

  • To extend the prospective ALL-SCT-BFM 2003 trial into a larger international consortium (ALL-SCT-BFMi).
  • To establish strict, standardized protocols for HLA-typing, donor selection, conditioning, GvHD prophylaxis, and supportive care.
  • To reduce treatment-related mortality and enhance graft-versus-leukemia (GVL) effects in pediatric HR or relapsed ALL.

Main Methods:

  • Initiation of the prospective, international, multicenter ALL-SCT-BFM 2003 trial, now extended to ALL-SCT-BFMi.
  • Implementation of strict guidelines for allogeneic SCT procedures, including HLA-typing, donor selection, and GvHD prophylaxis.
  • Comprehensive documentation and serious adverse event reporting to ensure study quality and facilitate failure management.

Main Results:

  • The study aims to determine the potential of various SCT procedures in HR or relapsed childhood ALL.
  • Standardized protocols are designed to minimize treatment-related mortality and optimize GVL effects.
  • Ongoing data collection and analysis will inform future treatment guidelines and improve patient outcomes.

Conclusions:

  • Prospective, standardized SCT trials are crucial for optimizing treatment for pediatric high-risk and relapsed ALL.
  • The ALL-SCT-BFMi consortium will provide valuable insights into the efficacy of different SCT approaches.
  • Strict adherence to standardized protocols is essential for improving survival and reducing complications in young ALL patients undergoing SCT.

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...